Osteoprotegerin and ligand of receptor activator of nuclear factor

Angle Orthodontist

Volumn 79, Issue 2, 2008, Pages 292-298

  Tan, Lijun ^a,b,c   Ren, Yijin ^d   Wang, Jun ^a   Jiang, Lingyong ^e   Cheng, Hui ^f   Sandham, Andrew ^d   Zhao, Zhihe ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^f Tianjin Union Medicine Centre   (China)

Author keywords

OPG; Ovariectomy; Periodontal ligament; RANKL; Tooth movement

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL; ARTICLE; FEMALE; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; INCISOR; MECHANICAL STRESS; MOLAR TOOTH; OSTEOCLAST; OVARIECTOMY; PATHOLOGY; PERIODONTAL DISEASE; PERIODONTAL LIGAMENT; PRESSURE; RAT; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INCISOR; MOLAR; OSTEOCLASTS; OSTEOPROTEGERIN; OVARIECTOMY; PERIODONTAL LIGAMENT; PRESSURE; RANK LIGAND; RATS; RATS, SPRAGUE-DAWLEY; STRESS, MECHANICAL; TIME FACTORS; TOOTH MOVEMENT;

EID: 63049134144     PISSN: 00033219     EISSN: 00033219     Source Type: Journal    
DOI: 10.2319/031608-150.1     Document Type: Article

References (29)

1. Meikle MC. Remodeling the dentofacial skeleton: the biological basis of orthodontics and dentofacial orthopedics. J Dent Res. 2007;86:12-24.
2. Ashizawa Y, Sahara N. Quantitative evaluation of newly formed bone in the alveolar wall surrounding the root during the initial stage of experimental tooth movement in the rat. Arch Oral Biol. 1998;43:473-484.
3. Ren Y, Kuijpers-Jagtman AM, Maltha JC. Immunohistochemical evaluation of osteoclast recruitment during experimental tooth movement in young and adult rats. Arch Oral Biol. 2005;509:1032-1039.
4. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337-442.
5. Theoleyre S, Wittrant Y, Tat SK, et al. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004;15:457-475.
6. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165-176.
7. Li J, Sarosi I, Yan XQ, et al. RANK is the intrinsic hematopoietic cell surface receptor that controls ostoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci. 2000;97:1566-1571.
8. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309-319.
9. Carnes DL, Maeder CL, Graves DT. Cells with osteoblastic phenotypes can be explanted from human gingiva and periodontal ligament. J Periodontol. 1997;68:701-707.
10. Kanzaki H, Chiba M, Shimizu Y, Mitani H. Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibition. J Dent Res. 2001;80:887-891.
11. Wada N, Maeda H, Tanabe K, et al. Periodontal ligament cells secrete the factor that inhibits osteoclastic differentiation and function: the factor is the osteoprotegerin/osteoclastogenesis inhibitory factor. J Periodontal Res. 2001;36:56-63.
12. Shiotani A, Shibasaki Y, Sasaki T. Localization of receptor activator of NFKB ligand, RANKL, in periodontal tissues during experimental movement of rat molars. J Electron Microsc. 2001;50:365-369.
13. Oshiro T, Shiotani A, Shibasaki Y, Sasaki T. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. Anat Rec. 2002;266:218-225.
14. Dervis E. Oral implications of osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:349-356.
15. Lund B, Sorensen OH, Lund B, Agner E. Serum 1,25-dihydroxyvitamin D in normal subjects and in patients with postmenopausal osteopenia: influence of age, renal function and oestrogen therapy. Horm Metab Res. 1982;14:271-274.
16. Cao T, Shirota T, Yamazaki M, Ohno K, Michi K. Bone mineral density in mandibles of ovariectomized rabbits. Clin Oral Impl Res. 2001;12:604-608.
17. Cao T, Shirota T, Ohno K, Michi KI. Mineralized bone loss in partially edentulous trabeculae of ovariectomized rabbit mandibles. J Periodont Res. 2004;39:37-41.
18. Yamashiro T, Takano-Yamamoto T. Influences of ovariectomy on experimental tooth movement in the rat. J Dent Res. 2001;80:1858-1861.
19. Miyazaki T, Matsunaga T, Miyazaki S, Hokari S, Komoda T. Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized rats. J Cell Biochem. 2004;93:503-512.
20. Thompson DD, Simmons HA, Pirie CM, Ke HZ. FDA guidelines and animal models for osteoporosis. Bone. 1995;17(suppl):S125-S133.
21. Roudebush RE, Magee DE, Benslay DN, Bendele AM, Bryant HU. Effect of weight manipulation on bone loss due to ovariectomy and the protective effects of estrogen in the rats. Calcif Tissue Int. 1993;53:61-64.
22. Comelekoglu U, Bagis S, Yalin S, et al. Biomechanical evaluation in osteoporosis: ovariectomized rat model. Clin Rheumatol. 2007;26:380-384.
23. Tanaka M, Ejiri S, Toyooka E, Kohno S, Ozawa H. Effects of ovariectomy on trabecular structures of rat alveolar bone. J Periodont Res. 2002;37:161-165.
24. Di Gregorio GB, Yamamoto M, Ali AA, et al. Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17β-estradiol. J Clin Invest. 2001;107:803-812.
25. Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992;257:88-91.
26. Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest. 1994;94:2397-2406.
27. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 1998;95:3597-3602.
28. Passeri G, Girasole G, Jilka RL, Manolagas SC. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology. 1993;133:822-828.
29. Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med. 2001;79:243-253.